Parenteral Nutrition Market

Global Parenteral Nutrition Market is valued at USD 6145.2 Million in 2020 and expected to reach USD 9301.3 Million by 2027 with a CAGR of 6.1% over the forecast period.

Global Parenteral Nutrition Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027. Growing prevalence of malnutrition among children’s, rising prevalence of chronic diseases, and increasing geriatric population are some of the major factors anticipated to drive the growth the Global Parenteral Nutrition Market.

Scope of Global Parenteral Nutrition Market Report:

Parenteral nutrition is a procedure in which there is intravenous feeding of nutrition into the body through veins. The nutrition’s given by intravenous feeding is either total parenteral nutrition or only supplemental. It is frequently used in a medical condition where a patient is not able to get enough nutrients through the food due to the obstruction of the gastrointestinal tract. This guides to the not enough nourishment of the body. Carbohydrates, water, proteins, fats, electrolytes, vitamins, and minerals which are required for the building of tissue expenditure of energy, and other physiologic activities are provided by total parenteral nutrition.

The severe and massive trauma of the gastrointestinal tract can be treated by parenteral nutrition procedures, but the procedure but has become relatively common providing bowel rest and nutrition. Parenteral nutrition treatment utilized as a short-term provisional measure until either medical or surgical treatment corrects the gastrointestinal dysfunction. The first parenteral nutrition was invented by William Harvey in 1628. His disclosure is the physical reason for intravenous infusions.

Covid-19 pandemic has shown a positive effect on the growth of global parenteral nutrition market. Metabolic and nutritional disturbances are observed in patients seriously ill with COVID-19 patients. Hypertriglyceridemia is a metabolic complication in patients with acute respiratory distress syndrome (ARDS) in COVID-19 patients thus parenteral nutrition therapy utilized amongst patients for earlier recovery.

Global parenteral nutrition market is segmented on the basis of nutrition type, consumer, end-users and region & country level. On the basis of nutrient type, the parenteral nutrition market is segmented into carbohydrates, lipid emulsion, single dose amino acid solution, trace elements, vitamins and minerals. On the basis of consumer, the market is segmented into children and new-born, adults and on the basis of end-user the parenteral nutrition market is segmented into clinic, hospital, and others.

Parenteral Nutrition Companies:

Some of the key players in Global parenteral nutrition market are Allergan plc, B.Braun, Melsungen AG, Pfizer Inc., Fresenius Kabi AG, Grifols, S.A., Baxter International, Inc., Vifor Pharma Management Ltd., Sichuan Kelun Pharmaceutical Co., Ltd., and others.

Global Parenteral Nutrition Market Segmentation:

By Nutrition Type:

• Carbohydrates
• Lipid Emulsion
• Single Dose Amino Acid Solution
• Trace Elements
• Vitamins and Minerals

By Consumer Type:

• Children
• New-born
• Adults

By End-Users:

• Clinic
• Hospital

The regions covered in global parenteral nutrition market are North America, Europe, Asia-Pacific, Latin America and Rest of the World. On the basis of country level, the market of global Parenteral Nutrition Market is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.

News: Baxter Announced U.S. FDA Approval of Clinimix and Clinimix E with Higher Protein for Patients Requiring Parenteral Nutrition

On September 15th, 2020; Baxter International, Inc.  announced the U.S. Food and Drug Administration (FDA) authorization of another formulation of Clinimix Injections and Clinimix E Injections. A Clinimix and Clinimix E definition offers the most noteworthy protein in a multi-chamber sack in the U.S., permitting clinician’s greater adaptability in meeting their patients' nutritional objectives. Parenteral nutrition is an intravenous association of nutrition that accepts a huge part in lessening malnutrition and may consolidate proteins, lipids, carbohydrates, electrolytes, vitamins and other trace elements.

JW’s European Partner Launched 3rd-gen Parenteral Nutrition Solution in EU

On August 20^th, 2019; JW Life Science European partner Baxter Pharmaceutical, launched Finomel, a ready-to-use triple-chamber bag for parenteral nutrition (PN), in EU. Finomel is a third-generation nutrient solution that ideally combines omega-3 and omega-6, which promote patient recovery, and vitamin E, thus improving immunity. The product also contains the highest omega-3 content among the three-chamber PN products currently sold in the market. In detail, the product contains four lipid components; refined fish oil (20 percent), refined soybean oil (30 percent), olive oil (25 percent) and coconut oil (25 percent) as well as glucose and amino acids.

Growing Prevalence of Malnutrition among Children’s, Rising Prevalence of Chronic Diseases and Increasing Geriatric Population are Some of the Major Factors Driving the Market Growth

One of the major factors drive the development of global parenteral nutrition market is growing prevalence of malnutrition among children’s. Children’s with an inappropriately working gastrointestinal (GI) tract are malnourished, or experience risk of malnutrition is primarily given parenteral nourishment treatment. Parenteral nutrition include; vitamins, lipids, minerals, and carbohydrates like calcium which important to children’s health. For instance; as per the World Health Organization (WHO), in 2020, around 45% of deaths among kids under 5 years old are connected to undernutrition. About half of kids' globally are younger than 5 years old experience from nutrient and mineral insufficiencies. Globally, maternal and neonatal deaths complete between 2.5 million and 3.4 million every year.

In addition, rising cases of chronic diseases is also fostering the market growth. In extreme medical conditions like AIDS, cancer, consumes, and gastrointestinal problems, the utilization of parenteral nourishment might become important. For instance, according to the Center for Disease Control and Prevention (CDC), about 422 million people have diabetic, globally.

Furthermore, increasing geriatric population is also supplementing the growth of global parenteral nutrition market. Increasing geriatric populace and adoption of parenteral nutrition strategy to oversee fundamental nutrients to older individuals to give and keep up with hydration levels, strength, and energy are also supplementing the market growth. These supplements include proteins, vital fats and minerals, carbohydrates, nutrients, electrolytes, and vital trace components. The number and percentage of individuals matured 60 years and older in the populace is expanding. For instance; according to the World Health Organization (WHO), in 2019, the quantity of individuals matured 60 years and older was 1 billion. This number will rise to 1.4 billion by 2030 and 2.1 billion by 2050.

However, increased use of internal nutrition and lack of alertness regarding different effective parenteral nutrition practices to recover patient health may hamper the global parenteral nutrition market growth. In spite of that, growing adoption of home healthcare can provide various opportunities for the further growth of the global parenteral nutrition market.

North America is Expected to Dominate the Global Parenteral Nutrition Market

North America is expected to dominate the global parenteral nutrition market during the forecast period due to the increasing cases of chronic diseases like cancer and diabetes, growing malnutrition among geriatric population and increased R&D investment by leading players in this region. For instance; according to World Health Organization (WHO); in 2018, about 2,378,785 new cancer cases were seen in North America. 

The Asia-Pacific region is expected to witness a fastest growth in the global parenteral nutrition market due to increasing cases of chronic diseases, growing awareness of parenteral nutrition and improving healthcare infrastructure in this region. For example; according to the American Society of Clinical Oncology Journal, the number of cancer patients in India in 2020 was approximately 1,392,179.

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy

Asia Pacific

• China
• Japan
• India
• Southeast Asia

Latin America

• Brazil
• Mexico

The Middle East and Africa

• GCC
• Africa
• Rest of the Middle East and Africa

Key Benefits of Global Parenteral Nutrition Industry Report-

• Global Parenteral Nutrition Industry report covers in-depth historical and forecast analysis.
• Global Parenteral Nutrition Market research report provides detailed information about market introduction, market summary, global market revenue (revenue USD), market drivers, market restraints, market opportunities, competitive analysis, Parenteral Nutrition Companiesregional, and country level.
• Global Parenteral Nutrition Industry report helps to identify opportunities in the marketplace.
• Global Parenteral Nutrition Market report covers extensive analysis of emerging trends and competitive landscape.

Parenteral Nutrition Trends

• Demand for  parenteral nutrition for children
• Preference For Amino Acid Food 

For More Parenteral Nutrition Trends Contact

Frequently Asked Questions (FAQ) :